Case report: Infection-associated HPS during pregnancy cured by HLH-94 protocol with induction therapy of ruxolitinib

Case report: Infection-associated HPS during pregnancy cured by HLH-94 protocol with induction therapy of ruxolitinib

Hemophagocytic syndrome (HPS) is a rapidly progressive and highly fatal disease, and is even more complex when it occurs during pregnancy. Currently, the HLH-94 protocol is commonly used for treatment for HPS, with ruxolitinib being mostly used for salvage therapy. Here, we report a pregnant woman w...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianqi Cen, Weixia Xuan, Shaohui Huang, Ziqi Wang, Lijun Shen, Moyuan Zhang, Jinzhou Fang, Shenying Yang, Xiaoju Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Immunology
Subjects:
hemophagocytic syndrome
pregnancy
ruxolitinib
HLH-94
induction therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1483257/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items